Antibiotic use in public hospitals in Vietnam between 2018 and 2022: a retrospective study

Vu Quoc Dat
DOI: https://doi.org/10.1136/bmjopen-2024-087322
IF: 3.006
2024-08-09
BMJ Open
Abstract:Objective: To assess the patterns of antibiotic consumption and expenditure in Vietnam. Design: This was a cross-sectional study. Setting: This study used data of antibiotic procurement that was publicly announced from 2018 to 2022 as a proxy for antibiotic consumption. Participants: This study included winning bids from 390 procurement units in 63 provinces in Vietnam for 5 years with a total expenditure of US$ 12.8 billions that represented for approximately 20-30% of the national funds spend on medicines. Interventions: Antibiotics were classified by WHO AWaRe (Access, Watch and Reserve) classification. Outcome measures: The primary outcomes were the proportions of antibiotic consumptions in number of defined daily doses (DDD) and expenditures. Results: There was a total of 2.54 million DDDs of systemic antibiotics, which accounted for 24.7% (US $3.16 billions) of total expenditure for medicines purchased by these public health facilities. The overall proportion of Access group antibiotics ranges from 40.9% to 53.8% of the total antibiotic consumption over 5 years. Conclusion: This analysis identifies an unmet target of at least 60% of the total antibiotic consumption being Access group antibiotics and an unreasonable share of expenditure for non-essential antibiotics in public hospitals in Vietnam.
What problem does this paper attempt to address?